Skip to main content
. 2016 May 6;107(6):853–861. doi: 10.1111/cas.12942

Figure 3.

Figure 3

Progression‐free survival (PFS) and overall survival (OS) according to MYC translocation and copy number gains in patients with diffuse large B‐cell lymphoma. (a,b) Analysis of MYC translocation as a prognostic factor for PFS (a) and OS (b). (c,d) Analysis of MYC copy number gains as a prognostic factor for PFS (c) and OS (d).